FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

16683002: Progesterone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
55641000195113 progesterone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835871000172110 progestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70691000195113 Progesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Progesterone Is a Ovarian hormone false Inferred relationship Some
Progesterone Is a Progestational hormone false Inferred relationship Some
Progesterone Is a Progesterone derivative false Inferred relationship Some
Progesterone Is a Pregnane (substance) true Inferred relationship Some
Progesterone Is a Steroid hormone true Inferred relationship Some
Progesterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progestational hormone false Inferred relationship Some
Progesterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Ovarian hormone false Inferred relationship Some
Progesterone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progesterone receptor agonist (disposition) true Inferred relationship Some
Progesterone Is a Progesterone receptor agonist true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing drospirenone and ethinylestradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Drospirenone 2 mg and estradiol 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing precisely megestrol acetate 125 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing drospirenone and estradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Drospirenone 500 microgram and estradiol 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Medroxyprogesterone acetate 400mg/mL injection suspension 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Desogestrel 75 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Norgestrel 75 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Medroxyprogesterone acetate 150mg/mL injection suspension 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Medroxyprogesterone acetate 400mg/mL injection suspension 2.5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Medroxyprogesterone 150mg/ml injection 1ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Medroxyprogesterone acetate 400mg/mL injection suspension 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Accidental progestogen poisoning Causative agent (attribute) False Progesterone Inferred relationship Some 1
Intentional progestogen poisoning Causative agent (attribute) False Progesterone Inferred relationship Some 1
Progestogen poisoning of undetermined intent Causative agent (attribute) False Progesterone Inferred relationship Some 1
Poisoning by progestogen Causative agent (attribute) False Progesterone Inferred relationship Some 1
Product containing estradiol and levonorgestrel (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing hydroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
caproate d'hydroxyprogestérone 250 mg/mL, ampoule de 1 mL pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Hydroxyprogestérone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Hydroxyprogesterone hexanoate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing gestonorone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Progesterone 100mg vaginal insert The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing progesterone in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Progesterone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Product containing progesterone in vaginal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Allergy to progesterone Causative agent (attribute) True Progesterone Inferred relationship Some 1
Free progesterone Is a False Progesterone Inferred relationship Some
Progesterone-releasing vaginal ring The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some 1
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Progesterone 200 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Some 1
Progesterone 200 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Progesterone 200 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Product containing precisely progesterone 100 milligram/2 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Progesterone Inferred relationship Some 1
Product containing precisely progesterone 100 milligram/2 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Progesterone Inferred relationship Some 1
Product containing precisely progesterone 50 milligram/1 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Progesterone Inferred relationship Some 1
Product containing precisely progesterone 50 milligram/1 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Progesterone Inferred relationship Some 1
Progesterone-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Progesterone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Progesterone only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Product containing only progesterone in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Progesterone only product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Progesterone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Some 1
Progesterone 50 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Progesterone 50 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Progesterone 40 mg/g vaginal gel This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Progesterone 40 mg/g vaginal gel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Progesterone 80 mg/g vaginal gel This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Progesterone 80 mg/g vaginal gel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Progesterone 100 mg vaginal tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Progesterone 100 mg vaginal tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Autoimmune progesterone dermatitis Causative agent (attribute) True Progesterone Inferred relationship Some 1
Progesterone 416.667 microgram/hour prolonged-release vaginal ring The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Progesterone 416.667 microgram/hour prolonged-release vaginal ring This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Progesterone Inferred relationship Some 1
Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Progesterone Inferred relationship Some 1
Serum progesterone measurement Component True Progesterone Inferred relationship Some 1
Saliva 17alpha-hydroxyprogesterone measurement (procedure) Component True Progesterone Inferred relationship Some 2

Start Previous Page 3 of 3


This concept is not in any reference sets

Back to Start